<?xml version="1.0"?>
<tei xml:space="preserve">
	<teiHeader>
		<fileDesc xml:id="0"/>
	</teiHeader>
	<text xml:lang="en">
			<front>Mar. Drugs 2013, 11, 788-799; doi:10.3390/md11030788 <lb/>Marine Drugs <lb/>ISSN 1660-3397 <lb/>www.mdpi.com/journal/marinedrugs <lb/>Article <lb/>Cytotoxic and Anti-Inflammatory Eunicellin-Based Diterpenoids <lb/>from the Soft Coral Cladiella krempfi <lb/>Chi-Jen Tai 1, † , Jui-Hsin Su 2,3, † , Chiung-Yao Huang 1 , Ming-Shyan Huang 4,5 , Zhi-Hong Wen 1 , <lb/>Chang-Feng Dai 6 and Jyh-Horng Sheu 1,7, * <lb/>1 Department of Marine Biotechnology and Resources, National Sun Yat-sen University, <lb/>Kaohsiung 804, Taiwan; E-Mails: jean801023@hotmail.com (C.-J.T.); <lb/>betty8575@yahoo.com.tw (C.-Y.H.); wzh@mail.nsysu.edu.tw (Z.-H.W.) <lb/>2 National Museum of Marine Biology &amp; Aquarium, Pingtung 944, Taiwan; <lb/>E-Mail: x2219@nmmba.gov.tw <lb/>3 Graduate Institute of Marine Biotechnology, National Dong Hwa University, Pingtung 944, Taiwan <lb/>4 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung <lb/>Medical University Hospital, Kaohsiung 807, Taiwan; E-Mail: shyang@cc.kmu.edu.tw <lb/>5 Center of Excellence for Environmental Medicine, Kaohsiung Medical University, <lb/>Kaohsiung 807, Taiwan <lb/>6 Institute of Oceanography, National Taiwan University, Taipei 112, Taiwan; <lb/>E-Mail: corallab@ntu.edu.tw <lb/>7 Division of Marine Biotechnology, Asia-Pacific Ocean Research Center, National Sun Yat-sen <lb/>University, Kaohsiung 804, Taiwan <lb/> † These authors contributed equally to this work. <lb/>* Author to whom correspondence should be addressed; E-Mail: sheu@mail.nsysu.edu.tw; <lb/>Tel.: +886-7-525-2000 (ext. 5030); Fax: +886-7-525-5020. <lb/>Received: 9 January 2013; in revised form: 6 February 2013 / Accepted: 19 February 2013 / <lb/>Published: 12 March 2013 <lb/>Abstract: Five new eunicellin-based diterpenoids, krempfielins E-I (1-5) and seven known <lb/>compounds (6-12) were isolated from the organic extract of a Taiwanese soft coral Cladiella <lb/>krempfi. The structures of the new metabolites were elucidated on the basis of extensive <lb/>spectroscopic analysis. Metabolites 5, 6, 10 and 12 were shown to exhibit cytotoxicity against a <lb/>limited panel of cancer cell lines. Furthermore, compounds 6 and 10 could potently inhibit <lb/>the accumulation of the pro-inflammatory iNOS protein, and 6 and 12 could significantly <lb/>reduce the expression of COX-2 protein in LPS-stimulated RAW264.7 macrophage cells. <lb/>OPEN ACCESS <lb/>Mar. Drugs 2013, 11 <lb/>789 <lb/>Keywords: <lb/>eunicellin-based <lb/>diterpenoids; <lb/>Cladiella <lb/>krempfi; <lb/>cytotoxicity; <lb/>anti-inflammatory agents <lb/></front>

			<body>1. Introduction <lb/>Previous studies showed that many eunicellin-based diterpenes discovered from soft corals exhibited <lb/>cytotoxic and anti-inflammatory activities [1-14]. The soft coral Cladiella krempfi has been found to <lb/>generate several types of metabolites including eunicellin-type diterpenoids [15] and pregnane-type <lb/>steroids [16-18]. Our previous chemical investigation of C. krempfi had led to the isolation of four new <lb/>eunicellin-based diterpenoids, krempfielins A-D [19]. In this paper, we further report the isolation of <lb/>five new eunicellin-based diterpenoids, krempfielins E-I (1-5) (Chart 1) and known compounds <lb/>6-methyl ether of litophynol B (6) [13], sclerophytin A (7) [20], sclerophytin B (8) [20], litophynin I <lb/>monoacetate (9) [21], 6-acetoxy litophynin E (10) [22], (1R*, 2R*, 3R*, 6S*, 9R*, 10R*, <lb/>14R*)-3-acetoxycladiell-7(16),11(17)-dien-6-ol (11) [23] and litophynin F (12) [24]. The structures of <lb/>metabolites 1-12 were characterized by extensive spectroscopic analysis. Cytotoxicity of all compounds <lb/>against five human tumor cell lines, lung adenocarcinoma (A549 and H1299), breast carcinoma <lb/>(BT483), liver carcinoma (HepG2), oral cancer (SAS) and one human lung bronchial cell (BEAS2B) <lb/>lines was studied. The ability of them to inhibit the up-regulation of pro-inflammatory iNOS (inducible <lb/>nitric oxide synthase) and COX-2 (cyclooxygenase-2) proteins in LPS (lipopolysaccharide)-stimulated <lb/>RAW264.7 macrophage cells was also evaluated. The results showed that compounds 5, 6, 10 and 12, in <lb/>particular 10, are cytotoxic towards the above cancer cell&apos;s compounds. Except 2, 4 and 11, these <lb/>compounds were found to significantly reduce the levels of iNOS protein; among them, 6 and 10 are <lb/>most active. Furthermore, 6 and 12 also could significantly reduce the expression of COX-2 protein. <lb/>Chart 1. Structures of metabolites 1-12. <lb/></body>

			<note place="headnote">Mar. Drugs 2013, 11 <lb/></note>

			<page>790 <lb/></page>

			<body>2. Results and Discussion <lb/>The new metabolite krempfielin E (1) showed the molecular ion peak [M + Na] + at m/z 487.2669 in <lb/>the HRESIMS and established a molecular formula of C 26 H 40 O 7 , implying seven degrees of unsaturation. <lb/>The IR absorptions bands at  max 3421 and 1732 cm -1 revealed the presence of hydroxy and ester <lb/>carbonyl functionalities. The 13 C NMR spectrum measured in CDCl 3 showed signals of twenty-six <lb/>carbons (Table 1) which were assigned by the assistance of the DEPT spectrum to four methyls <lb/>(including one acetate methyl δ C 21.0), seven sp 3 methylenes, two sp 2 methylenes, eight sp 3 methines <lb/>(including four oxymethines), one sp 3 and four sp 2 quaternary carbons (including two ester carbonyls).The <lb/>NMR spectroscopic data of 1 (Tables 1 and 2) showed the presence of two 1,1-disubstituted double <lb/>bonds (δ C 118.1 CH 2 , 112.0 CH 2 , 152.2 C, and 145.2 C; δ H 5.51 s, 5.22 s, 4.81 s, and 4.65 s). Two ester <lb/>carbonyls (δ C 172.5 and 171.2) were assigned from the 13 C NMR spectrum and their signals were <lb/>correlated with the methylene protons (δ H 2.10, 2H, m) of an n-butyrate and protons of an acetate methyl <lb/>(δ H 2.07 s, 3H), respectively. Therefore, the remaining three degrees of unsaturation identified 1 as a <lb/>tricyclic molecule. The 1 H-1 H COSY and HMBC correlations (Figure 1) were further used for <lb/>establishing the molecular skeleton of 1. The COSY experiment assigned three isolated consecutive <lb/>proton spin systems. Above evidences and the analysis of HMBC spectrum (Figure 1) suggested that 1 is <lb/>an eunicellin-based diterpenoid. Furthermore, the acetoxy group attaching at C-19 was confirmed by the <lb/>HMBC correlations from oxymethylene [δ H 3.94 (H 2 -19)] and acetate methyl protons (δ H 2.07) to the <lb/>ester carbonyl carbon appearing at δ 171.2 (C). Thus, the remaining one n-butyryloxy group had to be <lb/>positioned at C-3, an oxygen-bearing quaternary carbon resonating at δ 84.4 ppm. On the basis of above <lb/>analysis, the planar structure of 1 was established. <lb/>Table 1. 13 C NMR Data for Compounds 1-5. <lb/>C <lb/>1 a <lb/>2 a <lb/>3 b <lb/>4 b <lb/>5 a <lb/>1 <lb/>43.3, CH c <lb/>45.8, CH <lb/>44.7, CH <lb/>44.9, CH <lb/>46.6, CH <lb/>2 <lb/>91.4, CH <lb/>90.6, CH <lb/>90.9, CH <lb/>90.8, CH <lb/>92.6, CH <lb/>3 <lb/>84.4, C <lb/>84.7, C <lb/>84.2, C <lb/>84.6, C <lb/>85.6, C <lb/>4 <lb/>28.4, CH 2 <lb/>33.2, CH 2 <lb/>33.2, CH 2 <lb/>32.6, CH 2 <lb/>35.8, CH 2 <lb/>5 <lb/>35.3, CH 2 <lb/>30.2, CH 2 <lb/>29.7, CH 2 <lb/>38.3, CH 2 <lb/>28.5, CH 2 <lb/>6 <lb/>66.9, CH <lb/>214.8, C <lb/>217.0, C <lb/>213.4, C <lb/>82.3, CH <lb/>7 <lb/>152.2, C <lb/>48.3, CH <lb/>40.7, CH <lb/>40.6, CH <lb/>78.0, C <lb/>8 <lb/>77.3, CH <lb/>42.4, CH 2 <lb/>78.5, CH <lb/>37.7, CH 2 <lb/>78.5, CH <lb/>9 <lb/>83.7, CH <lb/>81.9, CH <lb/>85.5, CH <lb/>78.9, CH <lb/>78.3, CH <lb/>10 <lb/>47.9, CH <lb/>52.1, CH <lb/>47.5, CH <lb/>49.4, CH <lb/>52.0, CH <lb/>11 <lb/>145.2, C <lb/>142.1, C <lb/>141.0, C <lb/>141.6, C <lb/>148.5, C <lb/>12 <lb/>31.3, CH 2 <lb/>73.1, CH <lb/>72.8, CH <lb/>73.0, CH <lb/>31.6, CH 2 <lb/>13 <lb/>25.7, CH 2 <lb/>28.5, CH 2 <lb/>28.9, CH 2 <lb/>28.7, CH 2 <lb/>25.5, CH 2 <lb/>14 <lb/>39.1, CH <lb/>35.3, CH <lb/>35.6, CH <lb/>35.7, CH <lb/>44.0, CH <lb/>15 <lb/>22.2, CH 3 <lb/>22.3, CH 3 <lb/>22.6, CH 3 <lb/>22.6, CH 3 <lb/>22.8, CH 3 <lb/>16 <lb/>118.1, CH 2 <lb/>17.8, CH 3 <lb/>14.1, CH 3 <lb/>15.4, CH 3 <lb/>18.5, CH 3 <lb/>17 <lb/>112.0, CH 2 <lb/>118.1, CH 2 <lb/>119.5, CH 2 <lb/>118.7, CH 2 <lb/>109.2, CH 2 <lb/>18 <lb/>32.6, CH <lb/>28.0, CH <lb/>27.2, CH <lb/>27.5, CH <lb/>29.0, CH <lb/>19 <lb/>67.5, CH 2 <lb/>21.5, CH 3 <lb/>21.6, CH 3 <lb/>21.5, CH 3 <lb/>21.9, CH 3 <lb/></body>

			<note place="headnote">Mar. Drugs 2013, 11 <lb/></note>

			<page>791 <lb/></page>

			<body>Table 1. Cont. <lb/>20 <lb/>10.6, CH 3 <lb/>16.6, CH 3 <lb/>14.9, CH 3 <lb/>14.9, CH 3 <lb/>15.4, CH 3 <lb/>3-n-butyrate <lb/>172.5, C <lb/>37.4, CH 2 <lb/>18.5, CH 2 <lb/>13.6, CH 3 <lb/>172.5, C <lb/>37.3, CH 2 <lb/>18.4, CH 2 <lb/>13.7, CH 3 <lb/>173.1, C <lb/>36.5, CH 2 <lb/>18.4, CH 2 <lb/>13.8, CH 3 <lb/>3-OAc <lb/>169.6, C <lb/>22.4, CH 3 <lb/>169.7, C <lb/>22.3, CH 3 <lb/>6-OAc <lb/>171.6, C <lb/>21.4, CH 3 <lb/>8-n-butyrate <lb/>173.3, C <lb/>36.7, CH 2 <lb/>18.2, CH 2 <lb/>13.5, CH 3 <lb/>12-OAc <lb/>170.2, C <lb/>21.6, CH 3 <lb/>170.1, C <lb/>21.5, CH 3 <lb/>170.2, C <lb/>21.4, CH 3 <lb/>19-OAc <lb/>171.2, C <lb/>21.0, CH 3 <lb/>a Spectra recorded at 100 MHz in CDCl 3 . b Spectra recorded at 125 MHz in CDCl 3 . c Deduced from DEPT. <lb/>Table 2. 1 H NMR Data for Compounds 1-5. <lb/>H <lb/>1 a <lb/>2 a <lb/>3 b <lb/>4 b <lb/>5 a <lb/>1 <lb/>2.25 m <lb/>2.25 dd <lb/>(12.4, 7.2) <lb/>2.28 m <lb/>2.29 m <lb/>2.17 m <lb/>2 <lb/>3.71 br s <lb/>3.67 br s <lb/>3.81 br s <lb/>3.73 br s <lb/>3.63 br s <lb/>4 <lb/>1.64 m <lb/>2.25 m <lb/>2.03 m <lb/>2.75 dd <lb/>(14.4, 8.8) <lb/>2.23 m <lb/>2.46 m <lb/>2.19 m <lb/>2.52 dd <lb/>(5.5, 2.0) <lb/>1.96 m <lb/>2.65 m <lb/>5 <lb/>1.74 m <lb/>2.19 m <lb/>1.91 m <lb/>2.48 dd <lb/>(13.2, 11.2) <lb/>1.25 m <lb/>2.25 m <lb/>2.43 t (10.5) <lb/>1.56 m <lb/>6 <lb/>4.73 dd <lb/>(11.2, 4.0) c <lb/>5.71 d (5.6) <lb/>7 <lb/>2.58 m <lb/>2.32 m <lb/>2.68 m <lb/>8 <lb/>4.18 d (3.2) <lb/>1.88 m <lb/>2.00 m <lb/>3.77 d (8.5) <lb/>1.87 t (5.0) <lb/>2.24 m <lb/>5.27 d (9.2) <lb/>9 <lb/>4.19 d (6.8) <lb/>4.12 ddd <lb/>(11.6, 8.8, 4.4) <lb/>4.43 d (11.0) <lb/>4.23 dt <lb/>(10.0, 5.0) <lb/>4.11 t (8.8) <lb/>10 <lb/>2.87 dd <lb/>(10.8, 8.0) <lb/>3.12 t (7.6) <lb/>2.91 t (7.5) <lb/>3.07 td <lb/>(10.0, 1.5) <lb/>3.39 t (7.2) <lb/>12 <lb/>2.10 m <lb/>2.27 m <lb/>5.49 t (2.8) <lb/>5.52 br s <lb/>5.49 t (2.5) <lb/>2.03 m <lb/>2.23 m <lb/>13 <lb/>1.11 m <lb/>1.70 m <lb/>1.26 m <lb/>1.92 m <lb/>1.32 m <lb/>1.97 dt <lb/>(14.5, 3.0) <lb/>1.29 m <lb/>1.94 dt <lb/>(14.5, 3.0) <lb/>1.08 m <lb/>1.76 m <lb/></body>

			<note place="headnote">Mar. Drugs 2013, 11 <lb/></note>

			<page>792 <lb/></page>

			<body>Table 2. Cont. <lb/>14 <lb/>1.55 m <lb/>1.71 m <lb/>1.76 m <lb/>1.71 m <lb/>1.23 m <lb/>15 <lb/>1.63 s <lb/>1.40 s <lb/>1.49 s <lb/>1.48 s <lb/>1.38 s <lb/>16 <lb/>5.22 s <lb/>5.51 s <lb/>1.06 d (7.2) <lb/>1.26 d (6.5) <lb/>1.07 d (7.0) <lb/>1.08 s <lb/>17 <lb/>4.65 s <lb/>4.81 s <lb/>4.99 d (1.6) <lb/>5.91 d (1.6) <lb/>4.96 s <lb/>5.27 s <lb/>4.97 s <lb/>5.28 s <lb/>4.51 s <lb/>4.64 s <lb/>18 <lb/>2.08 m <lb/>1.76 m <lb/>1.84 m <lb/>1.81 m <lb/>1.69 m <lb/>19 <lb/>3.94 t (6.4) <lb/>0.91 d (6.8) <lb/>0.96 d (7.0) <lb/>0.93 d (6.5) <lb/>0.96 d (6.8) <lb/>20 <lb/>0.80 s <lb/>0.75 d (6.8) <lb/>0.78 d (7.0) <lb/>0.77 d (6.5) <lb/>0.77 d (6.8) <lb/>3-n-butyrate <lb/>2.10 m <lb/>1.57 m <lb/>0.92 t (7.2) <lb/>2.28 m <lb/>1.68 m <lb/>0.99 t (7.5) <lb/>2.25 m <lb/>1.68 m <lb/>0.98 t (7.6) <lb/>3-OAc <lb/>2.18 s <lb/>2.14 s <lb/>6-OAc <lb/>2.09 s <lb/>8-n-butyrate <lb/>2.55 m <lb/>1.61 m <lb/>0.96 t (7.2) <lb/>12-OAc <lb/>2.00 s <lb/>2.03 s <lb/>1.98 s <lb/>19-OAc <lb/>2.07 s <lb/>a Spectra recorded at 400 MHz in CDCl 3 . b Spectra recorded at 500 MHz in CDCl 3 . c J values (Hz) in parentheses. <lb/>Figure 1. Selected 1 H-1 H COSY (▬) and HMBC (→) correlations of 1, 2 and 5. <lb/>The relative structure of 1 was elucidated by the analysis of NOE correlations, as shown in Figure 2. <lb/>The observation of the NOE correlations of H-1 with H-10 and H 3 -20 suggested that these protons had <lb/>the same orientation and were assumed to be β-oriented. The NOE interactions found between the <lb/>oxymethine proton H-8 and H-10 assigned the α-orientation of the hydroxy group. Furthermore, the <lb/>NOE correlations of H-2 with both H-14 and H 3 -15; H-14 with both H-9 and H 2 -19; and H 3 -15 with H-6, <lb/>suggested that H-2, H-6, H-9, H-14, and H 3 -15 are α-oriented. Furthermore, the configuration of C-18 <lb/>was to be R* on the basis of NOE correlations of H-1/H 3 -20 and H-14/H 2 -19. The relative configuration <lb/>of 1 was thus established. Comparison of the 1 H and 13 C NMR spectroscopic data of 1 with those of its <lb/>19-deacetoxyl derivative, litophynol A [21], further confirmed the structure of 1. <lb/></body>

			<note place="headnote">Mar. Drugs 2013, 11 <lb/></note>

			<page>793 <lb/></page>

			<body>Figure 2. Key NOESY correlations for 1 and 2. <lb/>Krempfielin F (2) was found to have the molecular formula C 24 H 36 O 6 and seven degrees of <lb/>unsaturation, as indicated from the HRESIMS (m/z 443.2408 [M + Na] + ). The 13 C NMR spectrum of 2 <lb/>showed signals of twenty-four carbons (Table 1), which were characterized by the DEPT spectrum as six <lb/>methyls, five methylenes (including one sp 2 methylene), eight methines (including three oxygenated <lb/>carbons), and five quaternary carbons (including one ketone carbonyl, two ester carbonyls, and one sp 2 <lb/>quaternary carbon of an olefinic group). The presence of two acetoxy groups was indicated by the 1 H <lb/>NMR signals (Table 2) the 1 H NMR signals at δ H 2.18 (s, 3H) and 2.00 (s, 3H), and the 13 C NMR signals <lb/>at δ C 22.4 (CH 3 ), 21.6 (CH 3 ), 169.6 (C), and 170.2 (C). The remaining three degrees of unsaturation <lb/>again identified 2 as a tricyclic diterpenoid. The molecular framework was established by 1 H-1 H COSY <lb/>and HMBC experiments (Figure 1). The stereochemistry of compound 2 was also determined by the <lb/>NOESY spectrum (Figure 3), which exhibited NOE correlations of H-1 and with H-10 and H 3 -20, H-13β <lb/>(δ H 1.26) and with H-12 and H 3 -20, H-8β (δ H 1.88) with H-5β (δ H 2.48), H-10 and H 3 -16, H-5α with <lb/>H-4α and H 3 -15, and H 3 -16 with both H-8β (δ H 1.88) and H-5β (δ H 2.48), establishing the β-orientation <lb/>of H-12 and H 3 -16. On the basis of these results and other observed NOE correlations (Figure 2), the <lb/>structure of metabolite 2 was determined. <lb/>Figure 3. Key NOESY correlations for 5. <lb/>1 <lb/>2 <lb/>16 <lb/>15 <lb/>6 <lb/>7 <lb/>8 <lb/>9 <lb/>10 <lb/></body>

			<page>5 <lb/></page>

			<note place="headnote">Mar. Drugs 2013, 11 <lb/></note>

			<page>794 <lb/></page>

			<body>The HRESIMS (m/z 487.2675 [M + Na] + ) of 3 established the molecular formula of C 26 H 40 O 7 . <lb/>Comparison of the NMR data of 3 with those of 2 revealed the replacement of one acetoxy group <lb/>(δ H 2.18, 3H, s; δ C 169.6, C and 22.4, CH 3 ) in 2 by an n-butyryloxy group in 3 (δ H 0.99, 3H, t, J = 7.5 Hz; <lb/>1.68, 2H, m; 2.28, 2H, m; and δ C 172.5, C; 37.3, CH 2 ; 18.4, CH 2 and 13.7, CH 3 ), and an additional <lb/>hydroxy group substituted at C-8 of 3 that downfielded H-8 to δ H 3.77 and C-8 to δ C 78.5 ppm. The <lb/>placement of the n-butyryloxy group at C-3 was confirmed by the HMBC experiment which showed a <lb/>correlation between H-2 and the carbonyl carbon (δ C 172.5 C) of this n-butyryloxy group. The NOE <lb/>correlations of 3 also showed that the stereochemistry of this metabolite is identical with that of 2 <lb/>excepted for the presence of the α-oriented hydroxy group at C-8. <lb/>The HRESIMS of krempfielin H (4) exhibited a [M + Na] + ion peak at m/z 443.2408, appropriate for <lb/>a molecular formula of C 24 H 36 O 6 . By analysis of 2D NMR spectra, including 1 H-1 H COSY, HMQC, and <lb/>HMBC, compound 4 was shown to possess the same molecular framework as that of 2. Furthermore, it <lb/>was found that the NMR data of 4 were very similar to those of 2 (Tables 1 and 2), suggesting that 4 <lb/>might be an isomer of 2. From NOESY spectrum, it was found that the β-oriented H-10 showed NOE <lb/>interactions with both H-7 and H-8β (δ H 1.87), while H-8β showed NOE interactions with H-7, <lb/>indicating the β-orientation of H-7. This inferred the α-orientation of methyl substituent at C-7. Further <lb/>analysis of other NOE interactions revealed that 4 possessed the same relative configuration sat C-1, <lb/>C-2, C-3, C-9, C-10, C-12 and C-14 as those of 2. Therefore, 4 was found to be the C-7 epimer of 2. <lb/>The related metabolite, krempfielin I (5), had a molecular formula of C 30 H 48 O 8 as indicated by the <lb/>HRESIMS (m/z 559.3243, [M + Na] + ) and NMR data (Tables 1 and 2). The 13 C NMR spectrum of 5 <lb/>revealed the appearance of three ester carbonyls (δ C 173.3, 173.1 and 171.6), which were correlated with <lb/>protons of two methylenes (δ H 2.55, 2.25, m, each 2H; and δ C 36.7 and 36.5) of two n-butyrates and the <lb/>methyl protons (δ H 2.09 s, 3H and δ C 21.4) of one acetate group, respectively. The planar structure of 5 <lb/>was established by 1 H-1 H COSY and HMBC correlations (Figure 2). The HMBC connectivities from <lb/>H-2 (δ H 3.63 br s, 1H) and H-8 (δ H 5.27 d, 1H, J = 9.2 Hz) to two carbonyl carbons δ C 173.3 (C) and <lb/>173.1 (C) determined the positions of the two n-butyrates at C-8 and C-3. Also, the location of an acetate <lb/>group at C-6 was supported by the HMBC connectivities from both of the acetate methyl protons <lb/>(δ H 2.09 s, 3H) and oxygenated methine proton (δ H 5.71 d, 1H, J = 5.6 Hz) to the carbon resonating at <lb/>δ C 171.6 (C). The relative configuration of 5 was confirmed by analyzing the key NOE correlations <lb/>(Figure 3). <lb/>The cytotoxicity of the diterpenoids 1-12 against the growth of five human carcinoma cells A549, <lb/>BT483, H1299, HepG2, SAS and one human normal cell line BEAS2B was studied (Table 3). The <lb/>results showed that 1-4, 7-9 and 11 are not cytotoxic toward the above cancer and normal cells. <lb/>Compounds 5, 6, 10 and 12 exhibited cytotoxicity toward the above five cancer cell lines and the human <lb/>normal cell line; 10, being the most cytotoxic. The in vitro anti-inflammatory effects of compounds 1-12 <lb/>were also tested by examining the inhibitory activity of these compounds toward the LPS-induced <lb/>up-regulation of pro-inflammatory proteins iNOS and COX-2, in RAW264.7 macrophage cells <lb/>(Figure 4). At a concentration of 10 μM, compounds except 2, 4, and 11 were found to significantly <lb/>reduce the expression of iNOS protein, relative to the control cells stimulated with LPS only. Among <lb/>them, 6 and 10 could potently reduce the levels of iNOS protein to 6.4 ± 0.8% and 12.8 ± 2.9%, <lb/>respectively. Compounds 6 and 12 also effectively reduced COX-2 expression (52.5 ± 8.0% and <lb/>48.1 ± 10.8%, respectively) in the same LPS-stimulated cells. These results revealed that n-butyryloxy <lb/></body>

			<note place="headnote">Mar. Drugs 2013, 11 <lb/></note>

			<page>795 <lb/></page>

			<body>group at C-3 could significantly enhance the cytotoxic and anti-inflammatory activities in eunicellin-type <lb/>compounds. Overall, compounds 6, 10 and 12 exhibited interesting cytotoxic and anti-inflammatory <lb/>activity and could become lead compounds in the future drug development. <lb/>Table 3. Cytotoxicity (ED 50 μg/mL) of compounds 5, 6, 10 and 12. <lb/>Cell Lines <lb/>Normal Cell Line <lb/>Compounds <lb/>A549 <lb/>BT483 <lb/>H1299 <lb/>HepG2 <lb/>SAS <lb/>BEAS2B <lb/>5 <lb/>15.0 ± 3.5 <lb/>11.5 ± 1.8 <lb/>19.2 ± 4.0 12.9 ± 3.1 10.2 ± 3.5 <lb/>-a <lb/>6 <lb/>16.1 ± 1.2 <lb/>10.0 ± 1.8 <lb/>11.8 ± 1.0 <lb/>-a <lb/>17.2 ± 0.4 <lb/>10.4 ± 0.3 <lb/>10 <lb/>6.8 ± 1.0 <lb/>11.6 ± 2.8 <lb/>6.7 ± 0.7 <lb/>8.5 ± 1.3 <lb/>9.5 ± 3.7 <lb/>4.8 ± 0.7 <lb/>12 <lb/>12.2 ± 1.1 <lb/>6.8 ± 0.6 <lb/>12.8 ± 1.2 11.1 ± 0.4 10.3 ± 0.5 <lb/>13.6 ± 0.5 <lb/>Taxol <lb/>1.5 ± 0.9 <lb/>3.9 ± 0.8 <lb/>1.2 ± 0.1 <lb/>1.4 ± 0.7 <lb/>2.3 ± 1.5 <lb/>2.3 ± 1.5 <lb/>a IC 50 &gt; 20 μg/mL. <lb/>Figure 4. Effect of compounds 1-12 on LPS-induced iNOS and COX-2 proteins expression in <lb/>RAW264.7 macrophage cells by immunoblot analysis. The values are mean ± SEM. (n = 6). <lb/>Relative intensity of the LPS alone stimulated group was taken as 100%.* Significantly <lb/>different from LPS alone stimulated group (* P &lt; 0.05). a stimulated with LPS, b stimulated <lb/>with LPS in the presence of 1-12 (10 μM). <lb/>% of LPS-induced iNOS protein <lb/>0 <lb/>20 <lb/>40 <lb/>60 <lb/>80 <lb/>100 <lb/>120 <lb/>＊ <lb/>＊ <lb/>＊ <lb/>＊ <lb/>＊ <lb/>＊ <lb/>＊ <lb/>＊ <lb/>＊ <lb/>LPS a 1 b <lb/>4 b 5 b 6 b 7 b 8 b 9 b 10 b 11 b 12 b <lb/>2 b 3 b <lb/>% of LPS-induced COX-2 protein <lb/>0 <lb/>20 <lb/>40 <lb/>60 <lb/>80 <lb/>100 <lb/>120 <lb/>140 <lb/>LPS a <lb/>1 b <lb/>4 b <lb/>5 b <lb/>6 b <lb/>7 b <lb/>8 b <lb/>9 b <lb/>10 b <lb/>11 b <lb/>12 b <lb/>＊ <lb/>＊ <lb/>2 b <lb/>3 b <lb/>3. Experimental Section <lb/>3.1. General Experimental Procedures <lb/>Optical rotations were measured on a JASCO P-1020 polarimeter. IR spectra were recorded on a <lb/>JASCO FT/IR-4100 infrared spectrophotometer. ESIMS were obtained with a Bruker APEX II mass <lb/>spectrometer. NMR spectra were recorded either on a Varian UNITY INOVA-500 FT-NMR, a Varian <lb/>400MR FT-NMR. Silica gel (Merck, 230-400 mesh) was used for column chromatography. Precoated <lb/>silica gel plates (Merck, Kieselgel 60 F-254, 0.2 mm) were used for analytical TLC. High performance <lb/>liquid chromatography was performed on a Hitachi L-7100 HPLC apparatus with a ODS column <lb/>(25.0 × 21.2 mm, 5 μm). <lb/></body>

			<note place="headnote">Mar. Drugs 2013, 11 <lb/></note>

			<page>796 <lb/></page>

			<body>3.2. Animal Material <lb/>C. krempfi was collected by hand using scuba off the coast of Penghu islands of Taiwan in June 2008, <lb/>at a depth of 5-10 m, and stored in a freezer until extraction. A voucher sample (specimen no. <lb/>200806CK) was deposited at the Department of Marine Biotechnology and Resources, National Sun <lb/>Yat-sen University. <lb/>3.3. Extraction and Separation <lb/>The octocoral (1.1 kg fresh wt) was collected and freeze-dried. The freeze-dried material was minced <lb/>and extracted exhaustively with EtOH (3 × 10 L). The EtOH extract of the frozen organism was <lb/>partitioned between CH 2 Cl 2 and H 2 O. The CH 2 Cl 2 -soluble portion (14.4 g) was subjected to column <lb/>chromatography on silica gel and eluted with EtOAc in n-hexane (0%-100% of EtOAc, stepwise) and <lb/>then further with MeOH in EtOAc with increasing polarity to yield 41 fractions. Fraction 28, eluted with <lb/>n-hexane-EtOAc (1:2), was rechromatoraphed over a reversed-phase column (RP-18) using <lb/>acetone-H 2 O (10:1) as the mobile phase to afford six subfractions (A1-A6). Subfraction A1 was <lb/>repeatedly separated by reverse phase HPLC (CH 3 CN-H 2 O, 1:1 to 2:1) to afford compounds 1 (3.5 mg), <lb/>2 (4.9 mg), 3 (7.6 mg), 4 (4.8 mg), and 9 (3.6 mg). Subfraction A2 separated by reverse phase HPLC <lb/>(CH 3 CN-H 2 O, 3.8: 1) to afford compounds 5 (7.1 mg), 6 (16.4 mg), 10 (30.2 mg), 11 (5.2 mg) and <lb/>12 (5.4 mg). Subfraction A3 by reverse phase HPLC (CH 3 CN-H 2 O, 1:1) to afford compound 7 (13.2 mg). <lb/>Subfraction A4 by reverse phase HPLC (MeOH-H 2 O, 2.4:1) to afford compound 8 (5.5 mg). <lb/>3.3.1. Krempfielin E (1) <lb/>Colourless oil; [α] D <lb/>25 -78.3 (c 0.35, CHCl 3 ); IR (neat) ν max 3421, 3072, 2931, 1732, 1648, 1447, <lb/>1372, 1238, 1180 and 1039 cm -1 ; 1 H and 13 C NMR data, see Tables 1 and 2; ESIMS m/z 487 [M + Na] + ; <lb/>HRESIMS m/z 487.2669 [M + Na] + (calcd for C 26 H 40 O 7 Na, 487.2672). <lb/>3.3.2. Krempfielin F (2) <lb/>Colourless oil; [α] D <lb/>25 -7.3 (c 0.49, CHCl 3 ); IR (neat) ν max 3073, 2959, 1736, 1645, 1454, 1369, 1240, <lb/>1165 and 1095 cm -1 ; 1 H and 13 C NMR data, see Tables 1 and 2; ESIMS m/z 443 [M + Na] + ; HRESIMS <lb/>m/z 443.2408 [M + Na] + (calcd for C 24 H 36 O 6 Na, 443.2409). <lb/>3.3.3. Krempfielin G (3) <lb/>Colourless oil; [α] D <lb/>25 -26.3 (c 0.76, CHCl 3 ); IR (neat) ν max 3459, 3078, 2961, 1735, 1645, 1456, <lb/>1371, 1238, 1177 and 1075 cm -1 ; 1 H and 13 C NMR data, see Tables 1 and 2; ESIMS m/z 487 [M + Na] + ; <lb/>HRESIMS m/z 487.2675 [M + Na] + (calcd for C 26 H 40 O 7 Na, 487.2672). <lb/>3.3.4. Krempfielin H (4) <lb/>Colourless oil; [α] D <lb/>25 -5.8 (c 0.48, CHCl 3 ); IR (neat) ν max 3077, 2958, 1734, 1645, 1455, 1369, 1240, <lb/>1165 and 1095 cm -1 ; 1 H and 13 C NMR data, see Tables 1 and 2; ESIMS m/z 443 [M + Na] + ; HRESIMS <lb/>m/z 443.2408 [M + Na] + (calcd for C 24 H 36 O 6 Na, 443.2409). <lb/></body>

			<note place="headnote">Mar. Drugs 2013, 11 <lb/></note>

			<page>797 <lb/></page>

			<body>3.3.5. Krempfielin I (5) <lb/>Colourless oil; [α] D <lb/>25 -18.3 (c 0.35, CHCl 3 ); IR (neat) ν max 3460, 3069, 2960, 1733, 1646, 1448, <lb/>1370, 1254, 1181 and 1089 cm -1 ; 1 H and 13 C NMR data, see Tables 1 and 2; ESIMS m/z 559 [M + Na] + ; <lb/>HRESIMS m/z 559.3243 [M + Na] + (calcd for C 30 H 48 O 8 Na, 559.3247). <lb/>3.4. Cytotoxicity Testing <lb/>Cell lines were purchased from the American Type Culture Collection (ATCC). Cytotoxicity assays <lb/>of compounds 1-12 were performed using the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-<lb/>tetra-zolium bromide] colorimetric method [25,26]. <lb/>3.5. In Vitro Anti-Inflammatory Assay <lb/>Macrophage (RAW264.7) cell line was purchased from ATCC. In vitro anti-inflammatory activities <lb/>of compounds 1-12 were measured by examining the inhibition of lipopolysaccharide (LPS) induced <lb/>upregulation of iNOS (inducible nitric oxide synthetase) and COX-2 (cyclooxygenase-2) proteins in <lb/>macrophages cells using western blotting analysis [27,28]. <lb/>4. Conclusions <lb/>New eunicellin-based diterpenoids were isolated together with known ones from the soft coral <lb/>Cladiella krempfi. Compounds 5, 6, 10 and 12 showed cytotoxicity toward the above five cancer cell <lb/>lines, and one human normal cell line. Also, 6, 10 and 12 could significantly reduce the accumulation of <lb/>pro-inflammatory proteins iNOS and COX-2. Thus, these compounds, in particular 6, 10 and 12 could <lb/>be promising bioactive agents and may warrant further biomedical investigation. <lb/></body>

			<div type="acknowledgement">Acknowledgements <lb/>This research was supported by grants from the National Science Council (100-2320-B-110-001-MY2), <lb/>Taiwan, awarded to J.-H. Sheu. <lb/></div>

			<listBibl>References <lb/>1. Ahmed, A.F.; Wu, M.-H.; Wang, G.-H.; Wu, Y.-C.; Sheu, J.-H. Eunicellin-based diterpenoids, <lb/>australins A-D, isolated from the soft coral Cladiella australis. J. Nat. Prod. 2005, 68, 1051-1055. <lb/>2. Wu, S.-L.; Su, J.-H.; Wen, Z.-H.; Hsu, C.-H.; Chen, B.-W.; Dai, C.-F.; Kuo, Y.-H.; Sheu, J.-H. <lb/>Simplexins A-I, eunicellin-based diterpenoids from the soft coral Klyxum simplex. J. Nat. Prod. <lb/>2009, 72, 994-1000. <lb/>3. Chen, B.-W.; Wu, Y.-C.; Chiang, M.Y.; Su, J.-H.; Wang, W.-H.; Fan, T.-Y.; Sheu, J.-H. <lb/>Eunicellin-based diterpenoids from the cultured soft coral Klyxum simplex. Tetrahedron 2009, 65, <lb/>7016-7022. <lb/>4. Chen, Y.-H.; Tai, C.-Y.; Hwang, T.-L.; Weng, C.-F.; Li, J.-J.; Fang, L.-S.; Wang, W.-H.; <lb/>Wu, Y.-C.; Sung, P.-J. Cladielloides A and B: New eunicellin-type diterpenoids from an Indonesian <lb/>octocoral Cladiella sp. Mar. Drugs 2010, 8, 2936-2945. <lb/></listBibl>

			<note place="headnote">Mar. Drugs 2013, 11 <lb/></note>

			<page>798 <lb/></page>

			<listBibl>5. Chen, B.-W.; Chang, S.-M.; Huang, C.-Y.; Chao, C.-H.; Su, J.-H.; Wen, Z.-H.; Hsu, C.-H.; <lb/>Dai, C.-F.; Wu, Y.-C.; Sheu, J.-H. Hirsutalins A-H, eunicellin-based diterpenoids from the soft <lb/>coral Cladiella hirsuta. J. Nat. Prod. 2010, 73, 1785-1791. <lb/>6. Hassan, H.M.; Khanfar, M.A.; Elnagar, A.Y.; Mohammed, R.; Shaala, L.A.; Youssef, D.T.A.; <lb/>Hifnawy, M.S.; El Sayed, K.A. Pachycladins A-E, prostate cancer invasion and migration <lb/>inhibitory eunicellin-based diterpenoids from the Red Sea soft coral Cladiella pachyclados. <lb/>J. Nat. Prod. 2010, 73, 848-853. <lb/>7. Chen, B.-W.; Chao, C.-H.; Su, J.-H.; Wen, Z.-H.; Sung, P.-J.; Sheu, J.-H. Anti-Inflammatory <lb/>eunicellin-based diterpenoids from the cultured soft coral Klyxum simplex. Org. Biomol. Chem. <lb/>2010, 8, 2363-2366. <lb/>8. Wu, S.-L.; Su, J.-H.; Lu, Y.; Chen, B.-W.; Huang, C.-Y.; Wen, Z.-H.; Kuo, Y.-H.; Sheu, J.-H. <lb/>Simplexins J-O, eunicellin-based diterpenoids from a Dongsha Atoll soft coral Klyxum simplex. <lb/>Bull. Chem. Soc. Jpn. 2011, 84, 626-632. <lb/>9. Chen, Y.-H.; Tai, C.-Y.; Su, Y.-D.; Chang, Y.-C.; Lu, M.-C.; Weng, C.-F.; Su, J.-H.; Hwang, T.-L.; Wu, <lb/>Y.-C.; Sung, P.-J. Discovery of new eunicellins from an Indonesian octocoral Cladiella sp. Mar. <lb/>Drugs 2011, 9, 934-943. <lb/>10. Hsu, F.-J.; Chen, B.-W.; Wen, Z.-H.; Huang, C.-Y.; Dai, C.-F.; Su, J.-H.; Wu, Y.-C.; Sheu, J.-H. <lb/>Klymollins A-H, bioactive eunicellin-based diterpenoids from the Formosan soft coral <lb/>Klyxum molle. J. Nat. Prod. 2011, 74, 2467-2471. <lb/>11. Chen, B.-W.; Huang, C.-Y.; Wen, Z.-H.; Su, J.-H.; Wang, W.-H.; Sung, P.-J.; Wu, Y.-C.; Sheu, J.-H. <lb/>Klysimplexins U-X, eunicellin-based diterpenoids from the cultured soft coral Klyxum simplex. <lb/>Bull. Chem. Soc. Jpn. 2011, 84, 1237-1242. <lb/>12. Chen, B.-W.; Chao, C.-H.; Su, J.-H.; Tsai, C.-W.; Wang, W.-H.; Wen, Z.-H.; Huang, C.-Y.; <lb/>Sung, P.-J.; Wu, Y.-C.; Sheu, J.-H. Klysimplexins I-T, eunicellin-based diterpenoids from the <lb/>cultured soft coral Klyxum simplex. Org. Biomol. Chem. 2011, 9, 834-844. <lb/>13. Iwagawa, T.; Kusatsu, T.; Tsuha, K.; Hamada, T.; Okamura, H.; Furukawa, T.; Akiyama, S.; Doe, M.; <lb/>Morimoto, Y.; Iwase, F.; et al. Cytotoxic eunicellin-type diterpenes from the soft coral <lb/>Litophyton Viscudium. Heterocycles 2011, 83, 2149-2155. <lb/>14. Wu, S.-L.; Su, J.-H.; Huang, C.-Y.; Tai, C.-J.; Sung, P.-J.; Liaw, C.-C.; Sheu, J.-H. Simplexins P-S, <lb/>eunicellin-based diterpenes from the soft coral Klyxum simplex. Mar. Drugs 2012, 10, 1203-1211. <lb/>15. Sarma, N.S.; Chavakula, R.; Rao, I.N.; Kadirvelraj, R.; Row, T.N.G.; Saito, I. Crystal and molecular <lb/>structure of sclerophytin F methyl ether from the soft coral Cladiella krempfi. J. Nat. Prod. 1993, <lb/>56, 1977-1980. <lb/>16. Lan, W.-J.; Lin, C.-W.; Su, J.-Y.; Zeng, L.-M. Two steroidal glycosides from the soft coral <lb/>Cladiella krempfi. Chem. J. Chin. Univ. 2003, 24, 2019-2021. <lb/>17. Huang, X.-P.; Deng, Z.-W.; Ofwegen, L.V.; Li, J.; Fu, H.-Z.; Zhu, X.-B.; Lin, W.-H. Two new <lb/>pregnane glycosides from soft coral Cladiella krempfi. J. Asian Nat. Prod. Res. 2006, 8, 287-291. <lb/>18. Huang, X.-P.; Deng, Z.-W.; Zhu, X.-B.; Ofwegen, L.V.; Proksch, P.; Lin, W.-H. Krempenes A-D: <lb/>A series of unprecedented pregnane-type steroids from the marine soft coral Cladiella krempfi. <lb/>Helv. Chim. Acta 2006, 89, 2020-2026. <lb/>19. Tai, C.-J.; Su, J.-H.; Huang, M.-S.; Wen, Z.-H.; Dai, C.-F.; Sheu, J.-H. Bioactive eunicellin-based <lb/>diterpenoids from the soft coral Cladiella krempfi. Mar. Drugs 2011, 9, 2036-2045. <lb/></listBibl>

			<note place="headnote">Mar. Drugs 2013, 11 <lb/></note>

			<page>799 <lb/></page>

			<listBibl>20. Friedrich, D.; Doskotch, R.W.; Paquette, L.A. Revised constitution of sclerophytins A and B. Org. <lb/>Lett. 2000, 2, 1879-1882. <lb/>21. Miyamoto, T.; Yamada, K.; Ikeda, N.; Komori, T.; Higuchi, R. Bioactive terpenoids from <lb/>octocorallia, I. Bioactive diterpenoids: Litophynols A and B from the mucus of the soft coral <lb/>Litophyton sp. J. Nat. Prod. 1994, 57, 1212-1219. <lb/>22. Ochi, M.; Yamada, K.; Futatsugi, K.; Kotsuki, H.; Shibata, K. Litophynin D and E, two new <lb/>diterpenoids from a soft coral Litophyton sp. Chem. Lett. 1990, 19, 2183-2186. <lb/>23. Rao, C.B.; Rao, D.S.; Satyanarayana, C.; Rao, D.V.; Kassühlke, K.E.; Faulkner, D.J. New <lb/>cladiellane diterpenes from the soft coral Cladiella australis of the Andaman and Nicobar Islands. <lb/>J. Nat. Prod. 1994, 57, 574-580. <lb/>24. Ochi, M.; Yamada, K.; Futatsugi, K.; Kotsuki, H.; Shibata, K. Litophynins F, G, and H, three new <lb/>diterpenoids from a soft coral Litophyton sp. Heterocycles 1991, 32, 29-32. <lb/>25. Alley, M.C.; Scudiero, D.A.; Monks, A.; Hursey, M.L.; Czerwinski, M.J.; Fine, D.L.; Abbott, B.J.; <lb/>Mayo, J.G.; Shoemaker, R.H.; Boyd, M.R. Feasibility of drug screening with panels of human <lb/>tumor cell lines using a microculture tetrazolium assay. Cancer Res. 1988, 48, 589-601. <lb/>26. Scudiero, D.A.; Shoemaker, R.H.; Paull, K.D.; Monks, A.; Tierney, S.; Nofziger, T.H.; Currens, M.J.; <lb/>Seniff, D.; Boyd, M.R. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug <lb/>sensitivity in culture using human and other tumor cell lines. Cancer Res. 1988, 48, 4827-4833. <lb/>27. Lu, Y.; Huang, C.-Y.; Lin, Y.-F.; Wen, Z.-H.; Su, J.-H.; Kuo, Y.-H.; Chiang, M.Y.; Sheu, J.-H. <lb/>Anti-inflammatory cembranoids from the soft corals Sinularia querciformis and Sinularia granosa. <lb/>J. Nat. Prod. 2008, 71, 1754-1759. <lb/>28. Jean, Y.-H.; Chen, W.-F.; Duh, C.-Y.; Huang, S.-Y.; Hsu, C.-H.; Lin, C.-S.; Sung, C.-S.; Chen, I.-M.; <lb/>Wen, Z.-H. Inducible nitric oxide synthase and cyclooxygenase-2 participate in anti-inflammatory <lb/>and analgesic effects of the natural marine compound lemnalol from Formosan soft coral <lb/>Lemnalia cervicorni. Eur. J. Pharmacol. 2008, 578, 323-331. <lb/></listBibl>

			<div type="annex">Samples Availability: Not available. <lb/></div>

			<front>© 2013 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article <lb/>distributed under the terms and conditions of the Creative Commons Attribution license <lb/>(http://creativecommons.org/licenses/by/3.0/). </front>


	</text>
</tei>